ALK-Abello AS (ALK B):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ALK-Abello AS (ALK B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9871
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It markets diagnostics and other services to allergy clinics. The company’s allergy immunotherapy product portfolio includes tablet-based vaccines, sublingual or drop-based vaccines, subcutaneous vaccines; and adrenaline auto-injector to treat severe allergic reactions in emergencies (anaphylaxis). ALK’s research and development pipeline products include sublingual immunotherapy tablets for addressing the ragweed, house dust mite and tree pollen allergy. The company’s products target allergies caused by grass, tree, ragweed, house dust mite, Japanese cedar, dog, venom and cat, among others. It has subsidiaries in Europe, North America, Asia-Pacific and other international markets. ALK is headquartered in Horsholm, Denmark.

ALK-Abello AS (ALK B) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALK-Abello AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ALK-Abello AS, Medical Devices Deals, 2012 to YTD 2018 9
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ALK-Abello AS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alk Abello Enters into Co-Marketing Agreement with BioCSL 11
ALK-Abello Enters into Agreement with Seqirus 12
ALK-Abello Expands Partnership with Abbott Labs 13
ALK-Abello Enters Into Co-Marketing Agreement With Eddingpharm 14
ALK Enters Into Co-Promotion Agreement With MSD For Grazax 15
Licensing Agreements 16
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 16
Equity Offering 17
ALK-Abello Raises USD10.2 Million in Private Placement of AA Shares 17
ALK-Abello Raises USD101.5 Million in Private Placement of B Shares 18
Center Labs to Raise USD96 Million in Private Placement of Shares 19
Center Labs to Raise Funds through Private Placement of Shares 20
ALK-Abello AS – Key Competitors 21
ALK-Abello AS – Key Employees 22
ALK-Abello AS – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Aug 15, 2018: ALK-Abello: Six-month interim report (Q2) 2018 25
May 04, 2018: ALK Releases Three-month interim report (Q1) 2018 26
Feb 06, 2018: ALK releases its annual report 2017 27
Nov 10, 2017: ALK-Abello: Nine-month interim report (Q3) 2017 28
Aug 16, 2017: ALK-Abello: Six-month interim report (Q2) 2017 29
Aug 16, 2017: ALK: Six-month interim report (Q2) 2017 30
May 09, 2017: ALK-Abello Announces Three-month interim report (Q1) 2017 31
Feb 07, 2017: ALK releases its annual report 2016 32
Corporate Communications 33
Nov 03, 2017: ALK appoints Soren Jelert as new Chief Financial Officer 33
Jul 31, 2017: Management change at ALK 34
Mar 03, 2017: ALK Appoints SVP of R&D for North America and International Markets 35
Jan 10, 2017: Carsten Hellmann joins ALK as new President and CEO 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
ALK-Abello AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALK-Abello AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALK-Abello AS, Deals By Therapy Area, 2012 to YTD 2018 8
ALK-Abello AS, Medical Devices Deals, 2012 to YTD 2018 9
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alk Abello Enters into Co-Marketing Agreement with BioCSL 11
ALK-Abello Enters into Agreement with Seqirus 12
ALK-Abello Expands Partnership with Abbott Labs 13
ALK-Abello Enters Into Co-Marketing Agreement With Eddingpharm 14
ALK Enters Into Co-Promotion Agreement With MSD For Grazax 15
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 16
ALK-Abello Raises USD10.2 Million in Private Placement of AA Shares 17
ALK-Abello Raises USD101.5 Million in Private Placement of B Shares 18
Center Labs to Raise USD96 Million in Private Placement of Shares 19
Center Labs to Raise Funds through Private Placement of Shares 20
ALK-Abello AS, Key Competitors 21
ALK-Abello AS, Key Employees 22
ALK-Abello AS, Subsidiaries 23

List of Figures
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ALK-Abello AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ALK-Abello AS (ALK B):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Envases Del Plata S.A.
    Envases Del Plata S.A. - Strategy, SWOT and Corporate Finance Report Summary Envases Del Plata S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Allergy Therapeutics Plc (AGY):製薬・医療:M&Aディール及び事業提携情報
    Summary Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alter …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Benchmark Electronics Inc (BHE):企業の財務・戦略的SWOT分析
    Benchmark Electronics Inc (BHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kuzbasskaya Toplivnaya Company:企業の戦略・SWOT・財務分析
    Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report Summary Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kbc Bank Ireland Plc:企業の戦略・SWOT・財務分析
    Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report Summary Kbc Bank Ireland Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • KapStone Paper and Packaging Corporation:企業の戦略・SWOT・財務情報
    KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report Summary KapStone Paper and Packaging Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Providence Service Corporation:戦略・SWOT・企業財務分析
    Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Aurora Health Care Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aurora Health Care Inc (AHC) is an integrated, not-for-profit, health care system that provides inpatient and outpatient health care in the State of Wisconsin. The organization offers its healthcare services to communities throughout eastern Wisconsin, northern Illinois and the upper peninsu …
  • Ygm Trading Ltd.
    Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Orion Corp (ORNBV):製薬・医療:M&Aディール及び事業提携情報
    Summary Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous …
  • Synthetic Biologics Inc (SYN):企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • Xcel Energy Inc:企業の発電所・SWOT分析2018
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Bel Fuse, Inc.:企業の戦略・SWOT・財務情報
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …
  • Wells Fargo & Company:企業のM&A・事業提携・投資動向
    Wells Fargo & Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wells Fargo & Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Triangle Energy (Global) Ltd (TEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Triangle Energy (Global) Ltd (Triangle Energy), formerly Maverick Energy Ltd, is an oil and gas company that explores and produces oil and natural gas reserves. The company operates oil and gas assets such as Reid’s Dome and Pase Field. It holds working interest and operates the Production S …
  • Airbus Group SE:企業の戦略・SWOT・財務情報
    Airbus Group SE - Strategy, SWOT and Corporate Finance Report Summary Airbus Group SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務情報
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DiGi.Com Berhad (DIGI):企業の財務・戦略的SWOT分析
    DiGi.Com Berhad (DIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆